法匹拉韦中间体

原料药法匹拉韦，2020年3月17日科技部生物中心宣布，该药安全性好、适应新型冠状病毒肺炎，疗效明确。该中间体：356783-28-3,含量：99%，现货：500g

 

备注：我公司尊重原研药公司的专利，提供该类原料药及中间体项目仅用于科学、医学研究。不做商业量销售。对于专利保护的市场，由卖方自行负责，并承担所有法律风险。

notes: None of the products will be supplied to countries in which this could be in conflict with existing patents.However, the final responsibility lies exclusively with the buyer.

Founded in 2002,Hangzhou FST Pharmaceutical Co.,Ltd is located in Jiande,the suburban Hangzhou city ，total area is 95000square meters. As a young and private owned enterprise with sophisticated synthesis technology, FST is engaged in development and production of advanced intermediate of APIs, specialy chemicals and nutritional supplement.The main product lines are cardiovascular products,gastro-intestinal products and weight control products